Romanian drugs maker Antibiotice Iasi will establish representative offices in Ukraine and Rep. of Moldova, according to the decision voted by shareholders at the Ordinary General Meeting held today, as the company informed the Bucharest Stock Exchange (BVB).
This comes after Antibiotice Iasi also opened a representative office in Vietnam last year.
Iasi-based pharmaceutical company posted a net profit of over RON 33.5 million last year, up 1.1 percent compared to 2016.
After the first nine months of 2017, Antibiotice maintained its leading position in terms of generic drugs sold to hospitals, with a market share of 17.6 percent.
The company ranks 4th among the manufacturers of generic drugs, with a market share of 5.4 percent, and the 17th among all the pharmaceutical companies operating in Romania, with a market share of 2.3 percent.